Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
4.110
+0.140 (3.53%)
Nov 21, 2024, 10:43 AM EST - Market open
Inovio Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -112.88 | -135.12 | -279.82 | -303.66 | -166.41 | -119.36 | Upgrade
|
| Depreciation & Amortization | 2.53 | 3.5 | 5.5 | 4.73 | 4.63 | 5.52 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | 0.32 | 1.07 | - | -4.09 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 12.5 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.06 | -5.73 | 10.39 | 4.86 | -1.11 | -0.47 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.35 | -0.77 | 4.06 | 0.99 | -31.97 | 3.09 | Upgrade
|
| Stock-Based Compensation | 7.55 | 11.07 | 22.56 | 26.34 | 15.65 | 10.9 | Upgrade
|
| Other Operating Activities | -0.11 | 0.12 | 0.19 | 0.68 | 76.4 | 6.01 | Upgrade
|
| Change in Accounts Receivable | 0.28 | 9.33 | -3.71 | 11.03 | -17.02 | 2.02 | Upgrade
|
| Change in Accounts Payable | 0.31 | -45.99 | 32.61 | 26.14 | 3.25 | -4.59 | Upgrade
|
| Change in Unearned Revenue | -3.83 | -2.45 | -2.12 | -3.01 | 0.56 | 2.53 | Upgrade
|
| Change in Other Net Operating Assets | -0.81 | 28.85 | -6.95 | 16.19 | -57.87 | -3.51 | Upgrade
|
| Operating Cash Flow | -110.69 | -124.37 | -216.22 | -215.71 | -177.98 | -97.85 | Upgrade
|
| Capital Expenditures | -0.49 | -0.32 | -0.97 | -1.23 | -1.52 | -0.99 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.15 | 6.22 | - | - | - | - | Upgrade
|
| Divestitures | - | - | - | - | -2.77 | - | Upgrade
|
| Investment in Securities | 89.71 | 81.46 | 110.56 | -174.11 | -54.5 | -8.06 | Upgrade
|
| Investing Cash Flow | 89.37 | 87.36 | 109.59 | -175.34 | -58.8 | -9.04 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.17 | 97.44 | Upgrade
|
| Net Debt Issued (Repaid) | -16.42 | - | - | - | 0.17 | 97.44 | Upgrade
|
| Issuance of Common Stock | 24.86 | 5.46 | 83.24 | 216.11 | 466.76 | 9.2 | Upgrade
|
| Repurchase of Common Stock | -0.42 | -0.47 | -1.4 | -4.61 | -4.03 | -0.89 | Upgrade
|
| Other Financing Activities | 16.15 | - | - | - | 2.38 | -0.35 | Upgrade
|
| Financing Cash Flow | 24.17 | 5 | 81.84 | 211.5 | 465.28 | 105.4 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | -0 | -0.03 | -0.03 | 0.03 | - | Upgrade
|
| Net Cash Flow | 2.88 | -32.02 | -24.81 | -179.58 | 228.53 | -1.5 | Upgrade
|
| Free Cash Flow | -111.18 | -124.69 | -217.18 | -216.94 | -179.5 | -98.84 | Upgrade
|
| Free Cash Flow Margin | -54655.44% | -14986.17% | -2116.34% | -12223.61% | -2422.00% | -2403.69% | Upgrade
|
| Free Cash Flow Per Share | -4.39 | -5.62 | -10.92 | -12.47 | -13.89 | -12.01 | Upgrade
|
| Cash Interest Paid | 0.53 | 1.07 | 1.07 | 1.08 | 4.62 | 2.72 | Upgrade
|
| Levered Free Cash Flow | -69.47 | -86.15 | -115.43 | -123.41 | -109.58 | -62.45 | Upgrade
|
| Unlevered Free Cash Flow | -69.18 | -85.38 | -114.64 | -122.2 | -104.14 | -57.48 | Upgrade
|
| Change in Net Working Capital | 3.22 | 16.25 | -15.81 | -36.16 | 45.4 | 3.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.